Showing results (61-70 of 174) with videos related to
Sort By:
Pageof 18
Journal of Geriatric Oncology|September 30, 2025
Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignanciesAdel Shahnam, Nadia Hitchen, Sathya Manoharan, et al.Internal Medicine Journal|December 22, 2023
Telehealth in oncology: a cost analysis to evaluate the financial impact of implementing regional trial hubs within a phase 3 cancer clinical trialMarliese Alexander, Ian Collins, Patrick Abraham, et al.Cancers|January 11, 2019
Dynamic Thromboembolic Risk Modelling to Target Appropriate Preventative Strategies for Patients with Non-Small Cell Lung CancerMarliese Alexander, David Ball, Benjamin Solomon, et al.Oral Oncology|March 14, 2012
Correlation of Ataxia-Telangiectasia-Mutated (ATM) gene loss with outcome in head and neck squamous cell carcinomaAnnette M Lim, Richard J Young, Marnie Collins, et al.Oral Oncology|February 2, 2013
A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinomaAnnette M Lim, June Corry, Marnie Collins, et al.Thyroid : Official Journal of the American Thyroid Association|October 23, 2019
Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving ProtocolAmir Iravani, Benjamin Solomon, David A Pattison, et al.American Journal of Clinical Oncology|April 14, 2009
An open-label, single-arm phase two trial of gefitinib in patients with advanced or metastatic castration-resistant prostate cancerCarmel Pezaro, Mark A Rosenthal, Howard Gurney, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 20, 2019
Advanced-Stage Non-Small Cell Lung Cancer: Advances in Thoracic Oncology 2018Jordi Remon, Myung-Ju Ahn, Nicolas Girard, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 9, 2011
Everolimus in combination with pemetrexed in patients with advanced non-small cell lung cancer previously treated with chemotherapy: a phase I study using a novel, adaptive Bayesian dose-escalation modelJohan Vansteenkiste, Benjamin Solomon, Michael Boyer, et al.Pathology|August 17, 2017
Correlation between molecular analysis, diagnosis according to the 2015 WHO classification of unresected lung tumours and TTF1 expression in small biopsies and cytology specimens from 344 non-small cell lung carcinoma patientsPrudence A Russell, Toni-Maree Rogers, Benjamin Solomon, et al.Pageof 18